BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 27431290)

  • 21. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.
    Martínez F; Caro-Llopis A; Roselló M; Oltra S; Mayo S; Monfort S; Orellana C
    J Med Genet; 2017 Feb; 54(2):87-92. PubMed ID: 27620904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of
    Gao ZJ; Jiang Q; Chen XL; Chen Q; Ji XN; Mao YY; Feng S; Dong JJ; Xu KM
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3426-3432. PubMed ID: 30440138
    [No Abstract]   [Full Text] [Related]  

  • 23. Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.
    Järvelä I; Määttä T; Acharya A; Leppälä J; Jhangiani SN; Arvio M; Siren A; Kankuri-Tammilehto M; Kokkonen H; Palomäki M; Varilo T; Fang M; Hadley TD; Jolly A; Linnankivi T; Paetau R; Saarela A; Kälviäinen R; Olme J; Nouel-Saied LM; Cornejo-Sanchez DM; Llaci L; Lupski JR; Posey JE; Leal SM; Schrauwen I
    Hum Genet; 2021 Jul; 140(7):1011-1029. PubMed ID: 33710394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil.
    Leite AJDC; Pinto IP; Leijsten N; Ruiterkamp-Versteeg M; Pfundt R; de Leeuw N; da Cruz AD; Minasi LB
    PLoS One; 2022; 17(4):e0266493. PubMed ID: 35390071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal recessive mutations in THOC6 cause intellectual disability: syndrome delineation requiring forward and reverse phenotyping.
    Amos JS; Huang L; Thevenon J; Kariminedjad A; Beaulieu CL; Masurel-Paulet A; Najmabadi H; Fattahi Z; Beheshtian M; Tonekaboni SH; Tang S; Helbig KL; Alcaraz W; Rivière JB; Faivre L; Innes AM; Lebel RR; Boycott KM;
    Clin Genet; 2017 Jan; 91(1):92-99. PubMed ID: 27102954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next generation sequencing in nonsyndromic intellectual disability: from a negative molecular karyotype to a possible causative mutation detection.
    Athanasakis E; Licastro D; Faletra F; Fabretto A; Dipresa S; Vozzi D; Morgan A; d'Adamo AP; Pecile V; Biarnés X; Gasparini P
    Am J Med Genet A; 2014 Jan; 164A(1):170-6. PubMed ID: 24307393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage and exome analysis implicate multiple genes in non-syndromic intellectual disability in a large Swedish family.
    Lindholm Carlström E; Halvardson J; Etemadikhah M; Wetterberg L; Gustavson KH; Feuk L
    BMC Med Genomics; 2019 Nov; 12(1):156. PubMed ID: 31694657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort.
    Dias KR; Shrestha R; Schofield D; Evans CA; O'Heir E; Zhu Y; Zhang F; Standen K; Weisburd B; Stenton SL; Sanchis-Juan A; Brand H; Talkowski ME; Ma A; Ghedia S; Wilson M; Sandaradura SA; Smith J; Kamien B; Turner A; Bakshi M; Adès LC; Mowat D; Regan M; McGillivray G; Savarirayan R; White SM; Tan TY; Stark Z; Brown NJ; Pérez-Jurado LA; Krzesinski E; Hunter MF; Akesson L; Fennell AP; Yeung A; Boughtwood T; Ewans LJ; Kerkhof J; Lucas C; Carey L; French H; Rapadas M; Stevanovski I; Deveson IW; Cliffe C; Elakis G; Kirk EP; Dudding-Byth T; Fletcher J; Walsh R; Corbett MA; Kroes T; Gecz J; Meldrum C; Cliffe S; Wall M; Lunke S; North K; Amor DJ; Field M; Sadikovic B; Buckley MF; O'Donnell-Luria A; Roscioli T
    Genet Med; 2024 May; 26(5):101076. PubMed ID: 38258669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reanalysis of exome sequencing data of intellectual disability samples: Yields and benefits.
    Al-Nabhani M; Al-Rashdi S; Al-Murshedi F; Al-Kindi A; Al-Thihli K; Al-Saegh A; Al-Futaisi A; Al-Mamari W; Zadjali F; Al-Maawali A
    Clin Genet; 2018 Dec; 94(6):495-501. PubMed ID: 30125339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of clinical exome sequencing in the diagnostic procedure of patients with intellectual disability in clinical practice.
    Ballesta-Martínez MJ; Pérez-Fernández V; López-González V; Sánchez-Soler MJ; Serrano-Antón AT; Rodríguez-Peña LI; Barreda-Sánchez M; Armengol-Dulcet L; Guillén-Navarro E
    Orphanet J Rare Dis; 2023 Jul; 18(1):201. PubMed ID: 37480025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Yield of Intellectual Disability Gene Panels.
    Pekeles H; Accogli A; Boudrahem-Addour N; Russell L; Parente F; Srour M
    Pediatr Neurol; 2019 Mar; 92():32-36. PubMed ID: 30581057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
    Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
    BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and opportunities in the investigation of unexplained intellectual disability using family-based whole-exome sequencing.
    Helsmoortel C; Vandeweyer G; Ordoukhanian P; Van Nieuwerburgh F; Van der Aa N; Kooy RF
    Clin Genet; 2015 Aug; 88(2):140-8. PubMed ID: 25081361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-exome sequencing is a powerful approach for establishing the etiological diagnosis in patients with intellectual disability and microcephaly.
    Rump P; Jazayeri O; van Dijk-Bos KK; Johansson LF; van Essen AJ; Verheij JB; Veenstra-Knol HE; Redeker EJ; Mannens MM; Swertz MA; Alizadeh BZ; van Ravenswaaij-Arts CM; Sinke RJ; Sikkema-Raddatz B
    BMC Med Genomics; 2016 Feb; 9():7. PubMed ID: 26846091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability.
    Snoeijen-Schouwenaars FM; van Ool JS; Verhoeven JS; van Mierlo P; Braakman HMH; Smeets EE; Nicolai J; Schoots J; Teunissen MWA; Rouhl RPW; Tan IY; Yntema HG; Brunner HG; Pfundt R; Stegmann AP; Kamsteeg EJ; Schelhaas HJ; Willemsen MH
    Epilepsia; 2019 Jan; 60(1):155-164. PubMed ID: 30525188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the genetic heterogeneity of intellectual disability.
    Anazi S; Maddirevula S; Salpietro V; Asi YT; Alsahli S; Alhashem A; Shamseldin HE; AlZahrani F; Patel N; Ibrahim N; Abdulwahab FM; Hashem M; Alhashmi N; Al Murshedi F; Al Kindy A; Alshaer A; Rumayyan A; Al Tala S; Kurdi W; Alsaman A; Alasmari A; Banu S; Sultan T; Saleh MM; Alkuraya H; Salih MA; Aldhalaan H; Ben-Omran T; Al Musafri F; Ali R; Suleiman J; Tabarki B; El-Hattab AW; Bupp C; Alfadhel M; Al Tassan N; Monies D; Arold ST; Abouelhoda M; Lashley T; Houlden H; Faqeih E; Alkuraya FS
    Hum Genet; 2017 Nov; 136(11-12):1419-1429. PubMed ID: 28940097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of single nucleotide polymorphism-microarray and target gene sequencing in the study of genetic etiology of children with unexplained intellectual disability or developmental delay].
    Gao ZJ; Jiang Q; Cheng DZ; Yan XX; Chen Q; Xu KM
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):740-745. PubMed ID: 27784475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.